Policy & News
Cultivate a typical set of benchmarks Pharmaceutical craftsmen practice the initial heart
2023-06-21
On June 15, Gu Jiong of the Engineering Department of Kangrun Bio-technology was awarded the honorary title of "Four Drugs Cup" Changzhou's third "Pharmaceutical Craftsman" in the naming and commendation conference of "Four Drugs Cup" Changzhou Pharmaceutical Industry Association and Changzhou Pharmaceutical Quality Management Association.
View More
Promoting Integration with Competitions and Showing Style
2023-06-21
The first badminton match of "Kangrun Cup" was successfully held.
View More
Building Elites with Aggressiveness and Winning the Future with Concentration and Effort
2023-06-05
Jiangsu Kangrun Biotechnology Co., Ltd. 2023 New Employee Expansion Activities Successfully Conducted
View More
Pre season talk about influenza vaccines: correct cognition without hesitation
2023-09-12
Luwang, September 11th (Reporter Guan Xiaohui, Correspondent Li Chengxiu, Ma Jin) Influenza is an acute respiratory infectious disease caused by the influenza virus that poses a threat to human health. It is seasonal (commonly known as the "flu season") and can cause serious complications such as pneumonia, encephalitis, and even death in infants, young children, and the elderly. Therefore, outbreaks of COVID-19 are prone to occur in schools, kindergartens, and elderly care institutions. Although there was a nationwide outbreak of H1N1 influenza A from February to April this year, according to perennial epidemiological data in China, the southern and northern regions generally have a high incidence in winter and spring (November to February of the following year), and the areas south of the Yangtze River can also have a high incidence in summer. Therefore, we are currently in the pre flu season, which is the best time to receive influenza vaccines, especially for infants, young children, primary and secondary school students, the elderly, medical personnel, and entry-exit port staff. However, due to cognitive differences, some parents and vaccination populations have varying degrees of hesitation in vaccination, mostly suspecting the effective protection of the vaccine, followed by anxiety about vaccination safety. For this, let's talk about topics related to influenza vaccines together.
View More
The 2nd one in China! Kexing EV71-CA16 Bivalent HFMD Vaccine Approved for Clinical Use
2023-07-19
The 2nd one in China! Kexing EV71-CA16 Bivalent HFMD Vaccine Approved for Clinical Use
View More
2023-07-11
The most groundbreaking anti-cancer strategy of chimeric antigen receptor T-cell (CAR-T) therapy is to modify self-sourced T-cells so that they can more precisely target cancer cells. Globally, several CAR-T therapies have been approved, giving doctors a new weapon in the face of malignant tumours, especially haematological tumours, that they were previously unable to do anything about.
View More
